Company intelligence / Profile preview

BioMaje

Ownership: Private
Development stage: Other

Overview

BioMaje is an operational and strategic partner for biotechnology laboratories, specializing in bioproduction optimization, anti-infective strategies, and bacteriophage applications. The company offers field experience-driven support to help clients perfect or develop their bioproduction tools. It does not appear to have its own therapeutic pipeline or clinical results but instead acts as an expert consultant/service provider within the life sciences sector.

Therapeutic areas: Infectious Diseases
Modalities: Bacteriophage therapyBiologic production toolsAnti-infective agents
Industry: Consulting

Beyond the preview

Go deeper on BioMaje.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on BioMaje.

Explore the full profile